<?xml version="1.0" encoding="UTF-8"?>
<p>In September 2015, WHO issued new guidelines for HIV care, advocating for the immediate treatment of all infected persons, regardless of the level of CD4 count [
 <xref rid="pone.0202984.ref004" ref-type="bibr">4</xref>]. This "Treat-all" or "Test and Treat" strategy follows previous changes in minimum CD4 counts required for initiation of ART, which increased from 200 to 350 cells/mm
 <sup>3</sup> in 2010, to counts &lt; 500 cells/mm
 <sup>3</sup> in 2013 [
 <xref rid="pone.0202984.ref005" ref-type="bibr">5</xref>,
 <xref rid="pone.0202984.ref006" ref-type="bibr">6</xref>]. The latest recommendation encourages ART delivery in an increasingly short time frame, even immediately after confirmation of the diagnosis of HIV infection, simplifying the process ART initiation and thus reducing the attrition rate. It is a key strategy for achieving the second target of the "90-90-90" targets in 2020 [
 <xref rid="pone.0202984.ref007" ref-type="bibr">7</xref>].
</p>
